These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11361568)

  • 1. Nevirapine approved.
    AIDS Patient Care STDS; 1996 Dec; 10(6):378. PubMed ID: 11361568
    [No Abstract]   [Full Text] [Related]  

  • 2. Nevirapine approved by FDA. Food and Drug Administration.
    Bowersox J
    NIAID AIDS Agenda; 1996 Sep; ():10. PubMed ID: 11363918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nevirapine recommended for approval.
    BETA; 1996 Jun; ():6-7. PubMed ID: 11363650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-nucleoside reverse transcriptase inhibitors.
    Bowers M
    BETA; 1996 Jun; ():19-22. PubMed ID: 11363645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viramune (Nevirapine) is approved for children.
    Vazquez E
    Posit Aware; 1998; 9(6):17. PubMed ID: 11366470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA approves first new class of HIV drugs. Food and Drug Administration.
    AIDS Alert; 1996 Aug; 11(8):89. PubMed ID: 11363655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nevirapine surprise.
    Smart T
    GMHC Treat Issues; 1996; 10(6/7):25. PubMed ID: 11363640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nevirapine: new drug, new class, new questions.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1996 Jul; 2(7):8-13. PubMed ID: 11363750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nevirapine approval expands combo possibilities--and HIV suppression.
    Vazquez E
    Posit Aware; 1996; 7(5):9. PubMed ID: 11363791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination trial with nevirapine underway.
    AIDS Patient Care STDS; 1996 Apr; 10(2):130-1. PubMed ID: 11361693
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA looks at full approval for d4T. Food and Drug Administration.
    Posit Aware; 1996; 7(1):7. PubMed ID: 11363131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nevirapine expanded access.
    Posit Aware; 1996; 7(2):5. PubMed ID: 11363363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delavirdine (Rescriptor) approved.
    James JS
    AIDS Treat News; 1997 Apr; (No 269):1-3. PubMed ID: 11364252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA notifications. Tentative approval granted of generic nevirapine.
    AIDS Alert; 2007 Sep; 22(9):104-5. PubMed ID: 18415956
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA notifications. Tentative approval for generic nevirapine tablets.
    AIDS Alert; 2007 Oct; 22(10):118-9. PubMed ID: 18418905
    [No Abstract]   [Full Text] [Related]  

  • 16. Nevirapine is now available for use in HIV-infected children.
    Fac Notes (New Orleans La); 1999; 11(2):11. PubMed ID: 11810878
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA notifications. FDA gives tentative approval for stavudine, lamivudine & nevirapine tablet.
    AIDS Alert; 2009 Sep; 24(9):105-6. PubMed ID: 19938312
    [No Abstract]   [Full Text] [Related]  

  • 18. Nevirapine expanded access program begins.
    AIDS Patient Care STDS; 1996 Apr; 10(2):131. PubMed ID: 11361694
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA news. Food and Drug Administration.
    Res Initiat Treat Action; 1999 Jan; 5(1):20. PubMed ID: 11366229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA notifications. FDA approves label change for nevirapine.
    AIDS Alert; 2008 Aug; 23(8):91-2. PubMed ID: 18724490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.